|
RNF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.394800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.639000E-01 |
| Normal-vs-Stage2 |
2.593800E-01 |
| Normal-vs-Stage3 |
2.985800E-02 |
| Normal-vs-Stage4 |
9.692400E-01 |
| Stage1-vs-Stage2 |
1.909220E-01 |
| Stage1-vs-Stage3 |
1.177570E-02 |
| Stage1-vs-Stage4 |
9.404200E-01 |
| Stage2-vs-Stage3 |
6.013600E-01 |
| Stage2-vs-Stage4 |
3.578200E-01 |
| Stage3-vs-Stage4 |
1.022580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.228600E-01 |
| Normal-vs-AfricanAmerican |
4.070800E-01 |
| Normal-vs-Asian |
4.179800E-01 |
| Caucasian-vs-AfricanAmerican |
6.806400E-01 |
| Caucasian-vs-Asian |
2.476400E-01 |
| AfricanAmerican-vs-Asian |
2.291000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.339780E-01 |
| Normal-vs-Female |
5.385400E-01 |
| Male-vs-Female |
2.496300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.858800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.359200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.181800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.907800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.201800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.437800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.173800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.109800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.328600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.543200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.118400E-02 |
| Normal-vs-Grade 2 |
9.002000E-01 |
| Normal-vs-Grade 3 |
9.024000E-02 |
| Normal-vs-Grade 4 |
9.850400E-01 |
| Grade 1-vs-Grade 2 |
1.041250E-01 |
| Grade 1-vs-Grade 3 |
3.424200E-02 |
| Grade 1-vs-Grade 4 |
1.697180E-01 |
| Grade 2-vs-Grade 3 |
8.538500E-02 |
| Grade 2-vs-Grade 4 |
9.415600E-01 |
| Grade 3-vs-Grade 4 |
2.134600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.823400E-01 |
| Normal-vs-ccB subtype |
3.063600E-01 |
| ccA subtype-vs-ccB subtype |
1.621800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.531000E-01 |
| Normal-vs-N1 |
4.192200E-01 |
| N0-vs-N1 |
3.393200E-01 |
|
|
